Literature DB >> 10600936

rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger.

D H Sweet1, J B Pritchard.   

Abstract

The driving forces mediating tetraethylammonium (TEA) transport were systematically assessed in Xenopus oocytes and MDCK cells expressing organic cation transporter (OCT) 2 cloned from rat kidney (rOCT2). In rOCT2 cRNA-injected oocytes, uptake of [14C]TEA was saturable, with an estimated Michaelis constant (Km) of 393 microM, and was specifically inhibited by organic cations. Furthermore, TEA uptake demonstrated two distinct components, one that was potential sensitive and one that was pH sensitive. When membrane potential was intact, TEA uptake was largely unaffected by changes in medium pH; when the oocyte membrane was depolarized (K+ in = out = 102.5 mM, plus valinomycin), decreasing external medium pH significantly reduced TEA uptake. Consistent with the potential sensitivity of uptake, electrophysiological analysis of rOCT2-injected oocytes demonstrated movement of positive charge into the oocyte upon TEA addition. To further evaluate the nature of the pH effect and assess the properties of rOCT2 in a renal epithelium, rOCT2 was introduced into MDCK cells. A stably transfected single cell clone (MDCK-rOCT2) showed mediated, potential-sensitive, pH-sensitive TEA uptake (Km = 48 microM). TEA efflux from preloaded MDCK-rOCT2 cells was stimulated by externally applied (trans) tetramethylammonium but was trans-inhibited by H+ (external pH 5.4). The effect of external H+ was to modulate rOCT2-mediated transport. Thus rOCT2 is a potential-driven transporter, not an organic cation/H+ exchanger, consistent with a physiological role in the basolateral entry step in renal organic cation secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600936     DOI: 10.1152/ajprenal.1999.277.6.F890

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter.

Authors:  Shiro Itagaki; Vadivel Ganapathy; Horace T B Ho; Mingyan Zhou; Ellappan Babu; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2012-03-06       Impact factor: 3.922

2.  Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells.

Authors:  Li Xia; Karen Engel; Mingyan Zhou; Joanne Wang
Journal:  Am J Physiol Renal Physiol       Date:  2006-10-03

3.  Interspecies comparison of the functional characteristics of plasma membrane monoamine transporter (PMAT) between human, rat and mouse.

Authors:  Yoshiyuki Shirasaka; Nora Lee; Haichuan Duan; Horace Ho; Joanna Pak; Joanne Wang
Journal:  J Chem Neuroanat       Date:  2016-09-15       Impact factor: 3.052

Review 4.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

5.  OCT2 and MATE1 provide bidirectional agmatine transport.

Authors:  Tate N Winter; William F Elmquist; Carolyn A Fairbanks
Journal:  Mol Pharm       Date:  2010-12-03       Impact factor: 4.939

6.  The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK(1) cell monolayers.

Authors:  A J Dudley; K Bleasby; C D Brown
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

Review 7.  The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition.

Authors:  J Wang
Journal:  Clin Pharmacol Ther       Date:  2016-09-19       Impact factor: 6.875

8.  Uptake and efflux of quinacrine, a candidate for the treatment of prion diseases, at the blood-brain barrier.

Authors:  Shinya Dohgu; Atsushi Yamauchi; Fuyuko Takata; Yasufumi Sawada; Shun Higuchi; Mikihiko Naito; Takashi Tsuruo; Susumu Shirabe; Masami Niwa; Shigeru Katamine; Yasufumi Kataoka
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

9.  Transport of estrone sulfate by the novel organic anion transporter Oat6 (Slc22a20).

Authors:  Gloriane W Schnabolk; Geri L Youngblood; Douglas H Sweet
Journal:  Am J Physiol Renal Physiol       Date:  2006-02-14

10.  Pentavalent methylated arsenicals are substrates of human AQP9.

Authors:  Joseph R McDermott; Xuan Jiang; Lauren C Beene; Barry P Rosen; Zijuan Liu
Journal:  Biometals       Date:  2009-10-04       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.